Latent LabsTranslation site

4wks agorelease 7 00

Latent Labs is a cutting-edge AI platform for protein binding and molecular design that greatly simplifies the drug and biomolecule development process, supporting efficient, no-code operation.

Location:
United Kingdom, United States
Language:
en
Collection time:
2025-11-13
Latent LabsLatent Labs

Latent Labs It was founded by members of the DeepMind AlphaFold team. AI Biotechnology PlatformIt utilizes flagship AI tools. Latent-XIt completely revolutionizes the design process of protein binders and molecular drugs, supports custom protein targets and binding sites, and generates and screens high-quality new molecular structures with one click.The platform boasts significant advantages such as experimental verification, free access, and extremely high speed and efficiency.It is widely applicable to biopharmaceutical companies, research institutions, and AI drug development developers.Latent Labs is leading a new era of AI-driven molecular biology and protein drug discovery.

Latent LabsOfficial websiteAs a pioneering platform for AI content detection and molecular design, it was created by top teams including the co-developers of AlphaFold 2 and scientists from DeepMind, propelling drug design and biological research into a new era.


Latent Labs' main functions

In 2025, Latent Labs will launch its flagship platform. Latent-XThe goal is to make organisms "programmable," significantly improving the efficiency of molecular design in fields such as protein drugs, enzyme optimization, and genetic engineering.

1. AI-designed precise protein binding agents

With Latent-X at its core, the platform uses powerful AI technology to directly synthesize protein-binding agents at the atomic level.Supports uploading protein targets and custom epitopes.It can output molecular structures with one click and filter them by index scoring.

Latent-X platform interface screenshot
Photo/Latent-X platform interface screenshot
FunctionLatent Labs DescriptionRelated Links
Supported design typesMetacyclic peptides, Mini-BindersLatent-X Introduction
Binding affinity performanceMetacyclic peptides: mono/micromolar; Mini-Binder: picomolarExperiment Report
User operation thresholdNo programming required, full web-based workflowPlatform entrance
Structural Prediction and VisualizationIt features built-in overlay, scoring, and image display.Demo video

2. Extremely high hit rate and experimental verification

  • Metacyclic peptide design three target hit ratesGundam 91-100%
  • Mini-Binder five-target hit rate10-64%
  • The strongest binding affinity is superior to similar AI tools (such as RFdiffusion and AlphaProteo).

3. High-speed and efficient online design experience

Leveraging cutting-edge AI models and high-performance cloud computing,The generation efficiency is 10 times higher than that of traditional models.Molecular generation and structure determination are completed within seconds.

Related experimental reports
Photo/Related experimental reports
AI role-playing advertising banner

Chat endlessly with AI characters and start your own story.

Interact with a vast array of 2D and 3D characters and experience truly unlimited AI role-playing dialogue. Join now! New users receive 6000 points upon login!


Latent Labs Pricing & Solutions

Platform LaunchRegister and use immediatelyA free trial layer lowers the barrier to AI drug design.

Scheme typeillustratecostApplicable users
Free PlanRegister and use immediately; daily credit limit refreshed automatically.freeAll users, startups, academic institutions
Enterprise/Business EditionHigher computing power and usage, dedicated servicesContact the authorities for discussionPharmaceutical R&D teams and users with large demands
API Access PlanThe plan includes future support for automated integration.Not yet open (subject to commercial agreement).Developers, highly automated scenarios
Image
Image / Free Use Statement

Please refer to the Latent Labs pricing FAQ for details.


How to use Latent Labs

  1. Go to platform to register/login
  2. Upload protein target structure data
  3. Specify the epitope/hotspot.
  4. Choose either macrocyclic peptide or mini-binder type.
  5. One-click generation of dozens to hundreds of binder molecules
  6. Automatic sorting and scoring, selecting high-scoring solutions.
  7. Export sequences and 3D structures (non-exclusive license)
Registration Access Page
Photo/Registration Access Page

The platform greatly simplifies molecular design and lowers the barrier to AI protein design.

stepillustrateSupport Page
Platform RegistrationFree registration, one-click loginEntrance
Data UploadSupports multiple protein structure filesOfficial website guide
Target and hot zone definitionFreely defined binding sitesBuilt-in guide
Results intelligent sorting/filteringOptimization based on experimental scoringResults Page
Structure visualization and download3D visualization, supports exportPlatform Interface

Latent Labs' target audience

  • Innovative biopharmaceutical companiesShorten the new drug development cycle and reduce risks
  • Biotechnology startup teamNo need to build your own AI team to use cutting-edge tools
  • Universities and research institutionsLow barriers to entry promote protein research and experimental validation
  • AI/Pharmaceutical Industry DevelopersIn the future, APIs can be integrated into automated processes.

The platform's adaptability and future API support are particularly important for the integration and innovation of numerous disciplines.


The team and technology behind Latent Labs

The team members come from DeepMind AlphaFold 1/2/3, Microsoft, Stability AI, and others. CEO Simon Kohl said, "We are making biological research as engineerable as semiconductors."“

Team Page
Photo/Team Page
PositionRepresentativesBackground & Experience
Founder & CEOSimon KohlAlphaFold2 creators and former DeepMind team
Technical backboneAlex BridglandAlphaFold full-generation product development
Biological Algorithm EngineeringDave YuanZymergen, Mammoth Biosciences
Business/Platform ManagerMartha CarruthersPear Therapeutics

See moreTeam Page


Platform's unique advantages and future development

Latent Labs It sets new benchmarks in experimental validation, model innovation, rapid AI generation, and free access. In the future, it will support more molecular models such as nanobody and antibody-based drugs, contributing to drug diversity.

categoryKey features
Academic/Experimental AdaptabilityAll AI designs have been experimentally validated and demonstrate superior user-friendliness compared to traditional designs.
Interface and experienceNo local deployment required, zero-code web operation
Data security/complianceGDPR standards ensure strict data confidentiality.
Future expansionWill support antibody and API automation

Frequently Asked Questions

1. How does the platform ensure the validity of the generated structure?

All AI design structures use the same approach as those in the paper.in silico scoring systemBased on multi-target experimental verification, it is recommended that "PASS" subjects be used for experiments. See details.Technical Report

2. How are user data and privacy protected?

Privacy Policy
Photo/Privacy Policy

User-generated protein sequences and structuresNon-exclusive ownership by usersThe data is strictly protected in accordance with GDPR, used only for platform statistics, and will never be leaked. See details.Privacy Policy

3. What new features will emerge in the future?

The model will continue to iterate and will support nanobody, antibody, and API integration in the future, facilitating automated drug development.


As a key engine driving the future of programmable biology, Latent Labs injects unprecedented efficiency and innovation into protein design and drug discovery, and is open to the scientific and industrial communities. The era of "AI-driven biology" has arrived.

AI role-playing advertising banner

Chat endlessly with AI characters and start your own story.

Interact with a vast array of 2D and 3D characters and experience truly unlimited AI role-playing dialogue. Join now! New users receive 6000 points upon login!

data statistics

Data evaluation

Latent LabsThe number of visitors has reached 7. If you need to check the site's ranking information, you can click ""5118 Data""Aizhan Data""Chinaz data""Based on current website data, we recommend using Aizhan data as a reference. More website value assessment factors include:"Latent LabsAccess speed, search engine indexing and volume, user experience, etc.; of course, to evaluate the value of a website, the most important thing is to base it on your own needs and requirements, and some specific data will need to be obtained from [research institutions/resources].Latent LabsWe will negotiate with the website owner to provide information such as the website's IP addresses, page views (PV), and bounce rate.

aboutLatent LabsSpecial Announcement

This site's AI-powered navigation is provided by Miao.Latent LabsAll external links originate from the internet, and their accuracy and completeness are not guaranteed. Furthermore, AI Miao Navigation does not have actual control over the content of these external links. As of 5:40 PM on November 13, 2025, the content on this webpage was compliant and legal. If any content on the webpage becomes illegal in the future, you can directly contact the website administrator for deletion. AI Miao Navigation assumes no responsibility.

Relevant Navigation

No comments

none
No comments...